A-METHAPRED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover A-methapred, and when can generic versions of A-methapred launch?
A-methapred is a drug marketed by Abbott, Hospira, and Hospira Inc. and is included in fourteen NDAs.
The generic ingredient in A-METHAPRED is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for A-methapred
A generic version of A-METHAPRED was approved as methylprednisolone sodium succinate by FRESENIUS KABI USA on July 30th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for A-METHAPRED?
- What are the global sales for A-METHAPRED?
- What is Average Wholesale Price for A-METHAPRED?
Summary for A-METHAPRED
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 302 |
| DailyMed Link: | A-METHAPRED at DailyMed |
US Patents and Regulatory Information for A-METHAPRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089576-001 | Feb 22, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040664-001 | Dec 20, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 089575-001 | Feb 22, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
